Medical Procono: Facing the data directly, using data capabilities to improve the level of drug research

The 7th BiG Annual Conference will be held at Shanghai Sanjiagang Greenland International Conference Center from May 28th to 29th, 2021.

The 7th BiG Annual Conference will be held at Shanghai Sanjiagang Greenland International Conference Center from May 28th to 29th, 2021.

The company has been committed to providing customers with compliant, professional, timely and international standard data management and statistical services.

The large amount of data accumulated in the process of drug R&D and production is a valuable resource that cannot be ignored.

In recent years, the intensive promulgation of new regulations related to drug research data has imposed stricter requirements on drug quality, and higher requirements for the integrity, authenticity, and traceability of drug research and development data.

In this context, my country's pharmaceutical research companies have relatively weak application capabilities for professional data analysis, and their understanding of medical statistics is obviously insufficient.

Faced with such a dilemma, Ms.

Since its establishment 6 years ago, Yipu Kenuo has undertaken more than 300 projects with international standard quality, serving customers including Hengrui, Hutchison Whampoa, CSPC, Junshi, Simcere, Luoxin, Roche Diagnostics and other well-known domestic and foreign pharmaceutical companies .

In the process of focusing on serving domestic innovative pharmaceutical companies, we have accumulated a wealth of experience in mathematics for phase I, II, and III projects, especially in the field of oncology, especially in the Sino-US double newspaper.

At the beginning of its establishment, Yipu Kenuo joined CDISC (Clinical Data Exchange Standards Association) and became the first CDISC member company in China, insisting on providing customers with high-quality services that meet CDISC standards at local prices.

CDISC is a non-profit organization established for the development of clinical research data standards.

Using the CDISC standard at the beginning of the project, on the one hand, it can save 70-90% of the time and cost of the start-up phase for drug R&D companies, and 60% of all resources in the entire trial; on the other hand, it can also effectively improve the quality and authenticity of the data.

Making data more efficient is what Yipu Ke Nuo has always been doing.

In order to meet customer needs and improve the company's professional level, the company has purchased Meddra dictionary, WHODrug dictionary, SAS software, WinNonLin software, JMP® Clinical software, and became an important partner of Medidata Rave & Balance three years ago.

On the basis of many years of project experience, the friends of Medical Pucno have independently developed five practical gadgets to help data managers and medical colleagues in clinical operations to manage data more conveniently, easily, freely and efficiently.

These are the actual needs discovered by the business colleagues of Yipu Kenuo during the project.

　　Simplicity of tools is bound to be the future trend of the industry, and letting everyone easily participate in data management is the ultimate aspiration of Medical Procono.
　　Simplicity of tools is bound to be the future trend of the industry, and letting everyone easily participate in data management is the ultimate aspiration of Medical Procono.

　　In recent years, my country's new drug research and development business has entered a period of rapid development.
Only by strengthening industry exchanges, all practitioners performing their duties, doing their best, and enhancing collaboration, can we work together hand in hand.
Yipu Kenuo looks forward to cooperating with you!

　　In recent years, China's new drug research and development business has entered a period of rapid development.
Only by strengthening industry exchanges, all practitioners performing their duties, doing their best, and enhancing collaboration, can we work together hand in hand.
Yipu Kenuo looks forward to cooperating with you!　　In recent years, China's new drug research and development business has entered a period of rapid development.
Only by strengthening industry exchanges, all practitioners performing their duties, doing their best, and enhancing collaboration, can we work together hand in hand.
Yipu Kenuo looks forward to cooperating with you!
 
Plant "war" virus? Japan's Ryukakusan AVSS health ingredient attracts attention